Emergent BioSolutions to Lay Off About 400 Employees
Emergent BioSolutions on Tuesday decided to cut 400 jobs, pivoting its focus on core products such as overdose reversal nasal spray Narcan and anthrax vaccines.
Reuters Health Information
source https://www.medscape.com/s/viewarticle/995257?src=rss
Reuters Health Information
source https://www.medscape.com/s/viewarticle/995257?src=rss
Comments
Post a Comment